Titre
Conference scene: Immune signatures in the tumor and beyond.
Type
éditorial
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Auteur(s)
Kandalaft, L.E.
Auteure/Auteur
Kalos, M.
Auteure/Auteur
Melief, C.J.
Auteure/Auteur
Speiser, D.E.
Auteure/Auteur
Coukos, G.
Auteure/Auteur
Liens vers les personnes
ISSN
1750-7448
Statut éditorial
Publié
Date de publication
2012
Volume
4
Numéro
8
Première page
761
Dernière page/numéro d’article
772
Langue
anglais
Notes
Publication types: Journal ArticlePublication Status: ppublish. Document Type: News Item.
Résumé
Led by key opinion leaders in the field, the Cancer Immunotherapy Consortium of the Cancer Research Institute 2012 Scientific Colloquium included 179 participants who exchanged cutting-edge information on basic, clinical and translational cancer immunology and immunotherapy. The meeting revealed how rapidly this field is advancing. The keynote talk was given by Wolf H Fridman and it described the microenvironment of primary and metastatic human tumors. Participants interacted through oral presentations and panel discussions on topics that included host reactions in tumors, advances in imaging, monitoring therapeutic immune modulation, the benefit and risk of immunotherapy, and immune monitoring activities. In summary, the annual meeting gathered clinicians and scientists from academia, industry and regulatory agencies from around the globe to interact and exchange important scientific advances related to tumor immunobiology and cancer immunotherapy.
PID Serval
serval:BIB_0447F37D562A
PMID
Date de création
2012-11-22T13:29:30.030Z
Date de création dans IRIS
2025-05-20T16:08:56Z